Background Nutritional deficiencies are common in patients with coeliac disease and they can cause osteopenia among other associated diseases. Reduced consumption of milk and dairy products may play a major role in determining low bone mass in patients with coeliac disease.
Aim We aimed to investigate milk and dairy products consumption in patients with coeliac disease compared with the general population.
Methods We examined the average consumption of milk and dairy products and the reasons for not consuming them. An online survey was sent by email to patients with coeliac disease on a gluten-free diet and aged 18–75. Matched controls were selected among volunteers who responded to the survey posted on the public access sites. Differences in frequencies and means between the two groups were calculated using the χ2 test and t-test, respectively. All tests were two-tailed with a significance level set at p<0.05.
Results 176 patients with coeliac disease and 528 controls participated in the study. We found that 22.2% of the patients with coeliac disease and 19.9% of controls did not drink fluid milk on a regular basis; lactose-free milk was preferred by 20.4% of the patients with coeliac disease and by 19% of controls (p=0.69). Only a minority of patients with coeliac disease contacted a doctor before having lactose-free milk, despite this being led by the presence of gastrointestinal symptoms. More patients with coeliac disease than the general population reported a breath test before avoiding milk and dairy products.
Conclusions There is no significant difference between patients with coeliac disease and controls in regular milk consumption. Follow-up visits for patients with coeliac disease could avoid unnecessary dietary restrictions.
- coeliac disease
- dairy products
- gastrointestinal symptoms
- lactose-free milk
This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/.
Statistics from Altmetric.com
What this paper adds
The damaged intestinal mucosa in coeliac disease may cause lactose intolerance.
Patients on a gluten-free diet frequently claim lactose intolerance and therefore avoid milk and dairy products.
We found that 22.2% of the patients with CeD and 19.9% controls do not drink fluid milk on a regular basis.
Lactose-free milk is chosen by 20.4% of patients with CeD and 19% of the controls.
In our study we describe that there is no significant difference between patients with coeliacdiseaseand controls in regular milk consumption- Follow-up visits for patients with coeliac disease could avoid unnecessary dietary restrictions.
Milk and dairy products contain lactose, a disaccharide made of galactose and glucose. The absorption of lactose by the intestine requires a brush border enzyme named lactase that carries out the hydrolyses of the disaccharide to its monosaccharides, which easily cross the small bowel mucosa. Lactase activity decays during childhood in the majority of human populations leading to adult-type hypolactasia.1 Lactose intolerance related to primary or secondary lactase deficiency may cause abdominal pain and distension, borborygmi, flatus and diarrhoea induced by bacterial metabolism of undigested lactose in dairy products.1 In untreated coeliac disease (CeD), the damaged intestinal mucosa may have reduced the lactase activity, causing lactose intolerance in those subjects. However, previous data suggest that also patients with CeD on a gluten-free diet frequently claim lactose intolerance and therefore avoid milk and dairy products.2 Recently, it has been demonstrated that there is no association between the type of adult hypolactasia gene mutations and CeD.3 Milk avoidance in patients with CeD may depend on the fact that lactose intolerance is determined not only by the expression of lactase gene but also by the dose of lactose, intestinal flora, gastrointestinal motility, small intestinal bacterial overgrowth and sensitivity of the gastrointestinal tract to the generation of gas and other fermentation products of lactose digestion4 and other unidentified factors.
Milk avoidance and consequent reduction of the intake of calcium is claimed to be one of the possible causes of osteopenia frequently found in patients with CeD.5–7 Recently, we showed that 22.2% (260/1173) of the population from Southern Italy avoid milk consumption and 18.1% (213/1173) drink lactose-free milk, even though among this only 10.3% had undergone a breath test for lactose tolerance, with positive results in 5.5% of the population. The reasons for milk avoidance were mainly gastrointestinal symptoms and the belief in its somewhat toxic effect on health.8
The present study aimed to investigate, using the same survey of the previous study,8 the milk and dairy products consumption in patients with CeD compared with the general population.
As previously reported,8 we used an online survey investigating the average consumption of milk and dairy products and the reasons for not consuming them. The survey consisted of 16 questions, and we calculated an average time of 5 min to complete it. The small number of questions and short answering time were devised to provide the best adherence and results.
Subjects aged 18–75 years and living in Campania (South Italy) were invited to answer the questionnaire online. The survey was sent by email to 317 patients with CeD on a gluten-free diet for at least 6 months. Consent was obtained as part of a study dealing with vitamin D levels, bone mass and nutrition in CeD funded by a grant from the advocacy group Fondazione Celiachia (Italy). Patients specifically accepted to participate in the related online studies.
We selected controls from the general population who responded to the survey that was posted on the public access sites as reported elsewhere8 creating two groups matched by gender, age and type of job and selecting three controls for each patient with CeD.
Categorical variables were expressed as frequency, continuous variables as mean±SD. Differences in frequencies and means between the two groups were calculated using the χ2 test and t-test, respectively. Covariates included sex, age (18–35, 35–49, 50–75), body mass index (BMI, kg/m2), classified as underweight (≤18.5), normal weight (>18.5–25), overweight (>25–30) and obese (>30), job type (classified as student, housewife, low-class, middle-class and high-class job based on average salary, retired and unemployed) and weekly physical activity. We chose the above covariates because they may be associated with dietary restrictions and gastrointestinal symptoms like irritable bowel syndrome.9–12 All tests were two-tailed with a significance level set at p<0.05. The data were analysed with STATA V.12. A biomedical statistician performed the statistical review of the study. We have followed the Strengthening the Reporting of Observational Studies in EpidemiologySTROBE guidelines for this study.
Forty-three of the 317 emails bounced back because of the incorrect email address or server problems; 176 out of 274 patients with CeD (64.2 %) responded to all questions of the survey and were included in the study; 528 matched controls were used for the analysis. Details on sex, age, BMI, job and physical activity of the two groups were reported in table 1.
Our study shows that milk consumption is similar between patients with CeD and control (p=0.69). We found that 22.2% of the patients with CeD and 19.9% controls do not drink fluid milk on a regular basis. Lactose-free milk is chosen by 20.4% of patients with CeD and 19% of the controls (table 2).
Among those who drink milk (regular or lactose free), 49.6% of patients with CeD and 54.4% controls drink a daily average of 250 mL of fluid milk (table 3). Most of the subjects start to consume lactose-free milk for personal choice (without any specific reason) or because of gastrointestinal problems. Only a minority of patients with CeD contacted a doctor before starting the use of lactose-free milk (5.5%), despite being driven to this change by gastrointestinal symptoms (41.7%) (table 4).
Although the high percentage of responders avoid regular milk, only a minority of them reported having undergone a breath test for lactose tolerance with positive results (table 5). However, more patients with CeD than the general population reported a breath test before avoiding milk and dairy products.
When considering only dairy products consumption, no patient with CeD and only 6 (1.1%) controls state that they do not eat dairy products on a regular basis, with most of them eating these products at least once a week (table 6). Subjects who rarely drank dairy products manly consumed lactose-free mozzarella, cheese, yoghurt or only parmesan cheese (table 6).
Our study shows that there is no significant difference between the patients with CeD and matched controls in the regular milk consumption.
This is, to our best knowledge, the first study investigating the milk and dairy products in CeDs in comparison with controls. The results indicate that in our population, the reduced calcium intake is not the dominant player in determining the low bone mass frequently found in patients with CeD.
Both patients with CeD and controls chose to avoid milk consumption because of their choice or because of gastrointestinal symptoms, without undergoing a breath test for lactose intolerance or consult a doctor.
As previously reported,8 the use of an online survey has both strengths and limitations. Our survey, to our best knowledge, is the first one conducted in a large Italian cohort whose results describe the milk habits of patients with CeD and controls from the general population. Online surveys are quite popular because they are convenient and easy to use. However, possible limitations are the recall bias, common in food questionnaires and the use of a non-standardised questionnaire. We discussed these limitations elsewhere.8 Being the questionnaire anonymous, we do not have any information regarding, for example, the compliance to the gluten-free diet, the antitransglutaminase antibodies values or the time from the CeD diagnosis.
The present data confirmed our previous results, adding the information that patients with CeD on a gluten-free diet avoid milk in a percentage similar to that of the general population. The most frequent cause of avoiding milk in patients with CeD is the persistence of gastrointestinal symptoms despite the starting of a gluten-free diet. There are several reasons for the persistence of symptoms in CeD on a gluten-free diet,2 such as dietary lapses and irritable bowel syndrome, and lactose intolerance is only one of them. Therefore, daily calcium absorption may be low in those who avoid dairy products and contributes, but not fully explains, to the frequent low bone mass observed in patients with CeD from the same country, both before and after the gluten-free diet.13 However, studies reported that dairy food intake is associated with higher bone mineral density among adults, particularly those with sufficient vitamin D status.14 15
Another aspect to take into consideration when dealing with the choice of food is that patients with CeD tend already to have psychological problems caused by dietary restriction.16 17 Therefore, our data suggest that doctors’ and dietitians’ advise during follow-up visits for patients with CeD on a gluten-free diet should focus on avoiding unnecessary restriction of milk and of dairy products which could further compromise their health and quality of life.
Contributors FZ and CC designed and performed the research and wrote the paper. FZ and PI analysed data. CB performed the research and reviewed the paper. All authors accepted the final version of the paper.
Funding The authors declare that they received a grant from Fondazione Celiachia (grant no. 008_FC_2015).
Disclaimer CONSORT 2010: the authors declare that the CONSORT 2010 statement guideline has been adopted.
Competing interests None declared.
Patient consent for publication Not required.
Ethics approval The study was approved by the by the Ethics Committee of the University of Salerno Campania Sud aut. No 25, 25.4.2015.
Provenance and peer review Not commissioned; externally peer reviewed.
Data sharing statement Data set is available from the last author at email@example.com. Consent for data sharing was obtained. All the data were anonymised, and risk of identification is inconsistent.
Author note Core tip: we examined the average consumption of milk and dairy products and the reasons for not consuming them in patients with coeliac disease compared with controls. We found that there is no significant difference between patients with coeliac disease and controls in the regular milk consumption.
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.